Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants
David W. Eyre, Donald Taylor, M. B. Purver, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 8, pp. 744-756
Open Access | Times Cited: 445

Showing 1-25 of 445 citing articles:

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study
Oliver J. Watson, Gregory Barnsley, Jaspreet Toor, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 9, pp. 1293-1302
Open Access | Times Cited: 1409
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2
Olha Puhach, Kenneth Adea, Nicolas Hulo, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1491-1500
Open Access | Times Cited: 330
SARS-CoV-2 viral load and shedding kinetics
Olha Puhach, Benjamin Meyer, Isabella Eckerle
Nature Reviews Microbiology (2022)
Open Access | Times Cited: 324
The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good
Kevin Bardosh, Alexandre de Figueiredo, Rachel Gur‐Arie, et al.
BMJ Global Health (2022) Vol. 7, Iss. 5, pp. e008684-e008684
Open Access | Times Cited: 236
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Jia Wei, Koen B. Pouwels, Nicole Stoesser, et al.
Nature Medicine (2022) Vol. 28, Iss. 5, pp. 1072-1082
Open Access | Times Cited: 221
Public health impact of covid-19 vaccines in the US: observational study
Amitabh B. Suthar, Jing Wang, Victoria Seffren, et al.
BMJ (2022), pp. e069317-e069317
Open Access | Times Cited: 161
COVID-19 Vaccination Hesitancy among Healthcare Workers—A Review
Christopher Peterson, Benjamin Lee, Kenneth Nugent
Vaccines (2022) Vol. 10, Iss. 6, pp. 948-948
Open Access | Times Cited: 159
Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
Ottavia Prunas, Joshua L. Warren, Forrest W. Crawford, et al.
Science (2022) Vol. 375, Iss. 6585, pp. 1151-1154
Open Access | Times Cited: 140
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 118
Shedding of Infectious SARS-CoV-2 Despite Vaccination
Kasen K. Riemersma, Luis A. Haddock, Nancy A. Wilson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 117
SARS‐CoV‐2 variants and vulnerability at the global level
Vivek P. Chavda, Aayushi Patel, Darsh D. Vaghasiya
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2986-3005
Open Access | Times Cited: 113
The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia
Martí Català, Núria Mercadé‐Besora, Raivo Kolde, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 3, pp. 225-236
Open Access | Times Cited: 98
Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals
Jiwon Jung, Ji Yeun Kim, Heedo Park, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2213606-e2213606
Open Access | Times Cited: 92
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
Felicity Liew, Shubha Talwar, Andy Cross, et al.
EBioMedicine (2022) Vol. 87, pp. 104402-104402
Open Access | Times Cited: 91
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 86
Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants
Clauber Henrique Souza da Costa, Camila Auad Beltrão de Freitas, Cláudio Nahum Alves, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 81
Role of COVID-19 Vaccines in SARS-CoV-2 Variants
Zhou Zhou, Yimiao Zhu, Ming Chu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 79
Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron
Olha Puhach, Kenneth Adea, Nicolas Hulo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 78
Shedding of infectious SARS-CoV-2 despite vaccination
Kasen K. Riemersma, Luis A. Haddock, Nancy A. Wilson, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010876-e1010876
Open Access | Times Cited: 76
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 65
Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
Jisun Lee, Matthew C. Woodruff, Eui Ho Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1305-1313
Open Access | Times Cited: 62
Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study
David W. Eyre, Matthias E. Futschik, Sarah Tunkel, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 8, pp. 922-932
Open Access | Times Cited: 49
SARS‐CoV‐2 in animals: susceptibility of animal species, risk for animal and public health, monitoring, prevention and control
José L. Gonzáles, Denise A. Marston
EFSA Journal (2023) Vol. 21, Iss. 2
Open Access | Times Cited: 48
SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection
Jernej Pušnik, Werner O. Monzon-Posadas, Jasmin Zorn, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 45
Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant
Charlotte B. Acharya, John Schrom, Anthea Mitchell, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 5
Open Access | Times Cited: 62
Page 1 - Next Page

Scroll to top